CRISPR Therapeutics Announces Exclusive License of Lipid Nanoparticle Technologies Developed at MIT – GlobeNewswire (press release)
CRISPR Therapeutics Announces Exclusive License of Lipid Nanoparticle Technologies Developed at MITGlobeNewswire (press release)BASEL, Switzerland and CAMBRIDGE, Mass., May 08, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceut… Continue reading
